We are live on ! Find out more
FRA

Frank Rimerman Advisors Portfolio holdings

AUM $1.53B
1-Year Est. Return 30.5%
This Fund
S&P 500
This Quarter Est. Return
+6.57%
1 Year Est. Return
+30.5%
3 Year Est. Return
+108.46%
5 Year Est. Return
+120.01%
10 Year Est. Return
AUM
$1.41B
AUM Growth
+$893M
Cap. Flow
+$825M
Cap. Flow %
58.38%
Top 10 Hldgs %
41.28%
Holding
546
New
210
Increased
263
Reduced
22
Closed
8

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$51.7M
2
AAPL icon
Apple
AAPL
+$51.5M
3
NVDA icon
NVIDIA
NVDA
+$41M
4
AMZN icon
Amazon
AMZN
+$29.1M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$26.2M

Sector Composition

Rank Sector Weight
1 Technology 26.72%
2 Communication Services 11.28%
3 Healthcare 7.21%
4 Financials 6.88%
5 Consumer Discretionary 5.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OMF icon
301
OneMain Financial
OMF
$6.9B
$608K 0.04%
+12,542
New +$616K
REGN icon
302
Regeneron Pharmaceuticals
REGN
$68.8B
$606K 0.04%
577
+574
+19,133% +$556K
NTES icon
303
NetEase
NTES
$76.5B
$604K 0.04%
+6,318
New +$601K
MDB icon
304
MongoDB
MDB
$24B
$599K 0.04%
+2,397
New +$757K
HAL icon
305
Halliburton
HAL
$27.9B
$597K 0.04%
+17,673
New +$652K
HES
306
DELISTED
Hess
HES
$595K 0.04%
4,033
+3,967
+6,011% +$608K
NICE icon
307
Nice
NICE
$5.29B
$591K 0.04%
+3,437
New +$707K
ELAN icon
308
Elanco Animal Health
ELAN
$12.4B
$589K 0.04%
+40,813
New +$652K
BDX icon
309
Becton Dickinson
BDX
$43.1B
$589K 0.04%
2,519
+2,478
+6,044% +$584K
CEG icon
310
Constellation Energy
CEG
$98B
$584K 0.04%
2,918
+2,909
+32,322% +$593K
CL icon
311
Colgate-Palmolive
CL
$72.6B
$575K 0.04%
5,927
+5,833
+6,205% +$538K
HTHT icon
312
Huazhu Hotels Group
HTHT
$12.4B
$568K 0.04%
+17,033
New +$643K
PBR icon
313
Petrobras
PBR
$121B
$567K 0.04%
39,127
+35,732
+1,052% +$556K
MTDR icon
314
Matador Resources
MTDR
$6.31B
$562K 0.04%
+9,426
New +$592K
BIO icon
315
Bio-Rad Laboratories Class A
BIO
$8.42B
$559K 0.04%
+2,048
New +$596K
JD icon
316
JD.com
JD
$40.8B
$558K 0.04%
+21,591
New +$633K
KRC icon
317
Kilroy Realty
KRC
$4.58B
$557K 0.04%
+17,871
New +$594K
GD icon
318
General Dynamics
GD
$105B
$554K 0.04%
1,911
+1,852
+3,139% +$542K
ROP icon
319
Roper Technologies
ROP
$36.3B
$554K 0.04%
982
+975
+13,929% +$526K
CVS icon
320
CVS Health
CVS
$137B
$551K 0.04%
9,324
+9,225
+9,318% +$577K
GBCI icon
321
Glacier Bancorp
GBCI
$6.55B
$548K 0.04%
+14,671
New +$545K
FCX icon
322
Freeport-McMoran
FCX
$90B
$547K 0.04%
+11,251
New +$567K
TTE icon
323
TotalEnergies
TTE
$193B
$541K 0.04%
+8,110
New +$577K
MTD icon
324
Mettler-Toledo International
MTD
$26.8B
$537K 0.04%
384
+381
+12,700% +$521K
MSM icon
325
MSC Industrial Direct
MSM
$7.02B
$536K 0.04%
+6,764
New +$601K

Similar funds

Frank Rimerman Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Frank Rimerman Advisors held 546 positions worth $1.41B, up 172% from $520M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Frank Rimerman Advisors deployed $825M of net new capital in Q2 2024, opening 210 new positions and adding to 263 existing holdings. Its largest new stake was Duolingo: 99,828 shares worth $20.8M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 10% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Procept Biorobotics, an estimated $4.16M trimmed.

  • Frank Rimerman Advisors's largest Q2 2024 buy was Duolingo: 99,828 shares worth $20.8M.
  • Frank Rimerman Advisors added most to Microsoft in Q2 2024, an estimated $51.7M increase.
  • Frank Rimerman Advisors's biggest Q2 2024 reduction was Procept Biorobotics, cutting an estimated $4.16M.
  • Frank Rimerman Advisors fully exited Happen Inc in Q2 2024, selling an estimated $171K.
  • Frank Rimerman Advisors's ten largest holdings make up 41% of its $1.41B portfolio in Q2 2024.
  • Frank Rimerman Advisors opened 210 new positions and closed 8 in Q2 2024.
  • Frank Rimerman Advisors's portfolio value rose 172% quarter-over-quarter to $1.41B.

Based on Frank Rimerman Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.